A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

Shankar Siva; Tomas Kron; Mathias Bressel; Marion Haas; Tao Mai; Shalini Vinod; Giuseppe Sasso; Wenchang Wong; Hien Le; Thomas Eade; Nicholas Hardcastle; Brent Chesson; Daniel Pham; Morten Hoyer; Rebecca Montgomery; David Ball

Journal article

A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

Shankar Siva, Tomas Kron, Mathias Bressel, Marion Haas, Tao Mai, Shalini Vinod, Giuseppe Sasso, Wenchang Wong, Hien Le, Thomas Eade, Nicholas Hardcastle, Brent Chesson, Daniel Pham, Morten Hoyer, Rebecca Montgomery, David Ball

BMC CANCER | BMC | Published : 2016

DOI: 10.1186/s12885-016-2227-z

Download PDF

University of Melbourne Researchers

David Ball Author The Sir Peter MacCallum Department of Oncology

Tomas Kron Author The Sir Peter MacCallum Department of Oncology

Shankar Siva Author The Sir Peter MacCallum Department of Oncology

Related Projects (1)

INVESTIGATING THE SAFETY AND EFFICACY, QUALITY OF LIFE, COST-EFFICIENCY AND IMMUNE POTENTIAL OF HIGH PRECISION LUNG RADIOTHERAPY

Grants

Awarded by Cancer Australia through the Priority-driven Collaborative Cancer Research Scheme

Funding Acknowledgements

This study has been peer reviewed by the National Health and Medical Research Council (NHRMC) 2014 grant round and funded by Cancer Australia through the Priority-driven Collaborative Cancer Research Scheme APP1082399.